So, when we talk about breast cancer, we usually think about three main receptors: estrogen, progesterone, and HER2. And most breast cancers have at least one of these receptors - but not TNBC. It's like it's wearing a badge of honor, saying "I'm triple negative, baby - I don't need any of those receptors!"
This makes TNBC super tricky to treat, because hormone therapies and targeted therapies don't work as well. It's like trying to find a key to a locked door, but the key doesn't fit - you need to find a whole new way in. And that's where things get really interesting.
